Cargando…

Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England

BACKGROUND: Dupuytren's disease is a fibro-proliferative disorder affecting ~3-5% of the UK population. Current surgical treatments for Dupuytren's contracture (DC) include fasciectomy and fasciotomy. We assessed the clinical management of DC in England over a 5-year period; associated NHS...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerber, Robert A, Perry, Richard, Thompson, Robin, Bainbridge, Christopher
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103491/
https://www.ncbi.nlm.nih.gov/pubmed/21486483
http://dx.doi.org/10.1186/1471-2474-12-73
_version_ 1782204526812463104
author Gerber, Robert A
Perry, Richard
Thompson, Robin
Bainbridge, Christopher
author_facet Gerber, Robert A
Perry, Richard
Thompson, Robin
Bainbridge, Christopher
author_sort Gerber, Robert A
collection PubMed
description BACKGROUND: Dupuytren's disease is a fibro-proliferative disorder affecting ~3-5% of the UK population. Current surgical treatments for Dupuytren's contracture (DC) include fasciectomy and fasciotomy. We assessed the clinical management of DC in England over a 5-year period; associated NHS costs were assessed for a 1-year period. METHODS: Hospital Episode Statistics were extracted from April 2003 to March 2008 for patients with Palmar Fascial Fibromatosis (ICD10 = M720) and DC-related procedures. Variables included demographics, OPCS, patient status and physician specialty. To estimate 2010-2011 costs, HRG4 codes and the National Schedule of Tariff 2010-11-NHS Trusts were applied to the 2007-2008 period. RESULTS: Over 5 years, 75,157 DC admissions were recorded; 64,506 were analyzed. Mean admissions per year were 12,901 and stable. Day cases increased from 42% (2003-2004) to 62% (2007-2008). The percent of patients having two or more admissions per year increased from 5.5% in 2003-2004 to 26.1% in 2007-2008. Between 2003 and 2007, 91% of procedures were Fasciectomy. Revision of Fasciectomy and Fasciotomy each accounted for ~4%; Amputation for 1%. In 2007, classification was extended to identify Digital Fasciectomy, its Revision and Dermofasciectomy. In 2007-2008, admissions were: 70% Palmar Fasciectomy, 16% Digital Fasciectomy, 1.3% Other Fasciectomy, 4.4% Revision of Palmar Fasciectomy, 1.3% Revision of Digital Fasciectomy, 3.8% Division of Palmar Fascia, 2.6% Dermofasciectomy and 1.1% Amputation. 79% of cases were overseen by trauma and orthopaedic surgeons, 19% by plastic surgeons. Mean (±SD) inpatient hospital length of stay was 1.5 (±1.4) days in 2003-2004 and 1.0 (±1.3) days in 2007-2008. Total estimated costs for 1 year (2010-2011) were £41,576,141. Per-patient costs were £2,885 (day case) and £3,534 (inpatient). Costs ranged from £2,736 (day-case Fasciectomy) to £9,210 (day-case Revision Digital). CONCLUSIONS: Between 2003 and 2008, fasciectomy was the most common surgical procedure for DC in England. While procedure rates and physician specialties varied little, there was a reversal in surgical venue: inpatient operations decreased as day-case procedures increased. The change is likely due to economic trends and changes to the healthcare system. Estimated costs for 2010-2011 varied by procedure type and patient status. These findings can be used to understand clinical management of DC and guide healthcare policy.
format Text
id pubmed-3103491
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31034912011-05-28 Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England Gerber, Robert A Perry, Richard Thompson, Robin Bainbridge, Christopher BMC Musculoskelet Disord Research Article BACKGROUND: Dupuytren's disease is a fibro-proliferative disorder affecting ~3-5% of the UK population. Current surgical treatments for Dupuytren's contracture (DC) include fasciectomy and fasciotomy. We assessed the clinical management of DC in England over a 5-year period; associated NHS costs were assessed for a 1-year period. METHODS: Hospital Episode Statistics were extracted from April 2003 to March 2008 for patients with Palmar Fascial Fibromatosis (ICD10 = M720) and DC-related procedures. Variables included demographics, OPCS, patient status and physician specialty. To estimate 2010-2011 costs, HRG4 codes and the National Schedule of Tariff 2010-11-NHS Trusts were applied to the 2007-2008 period. RESULTS: Over 5 years, 75,157 DC admissions were recorded; 64,506 were analyzed. Mean admissions per year were 12,901 and stable. Day cases increased from 42% (2003-2004) to 62% (2007-2008). The percent of patients having two or more admissions per year increased from 5.5% in 2003-2004 to 26.1% in 2007-2008. Between 2003 and 2007, 91% of procedures were Fasciectomy. Revision of Fasciectomy and Fasciotomy each accounted for ~4%; Amputation for 1%. In 2007, classification was extended to identify Digital Fasciectomy, its Revision and Dermofasciectomy. In 2007-2008, admissions were: 70% Palmar Fasciectomy, 16% Digital Fasciectomy, 1.3% Other Fasciectomy, 4.4% Revision of Palmar Fasciectomy, 1.3% Revision of Digital Fasciectomy, 3.8% Division of Palmar Fascia, 2.6% Dermofasciectomy and 1.1% Amputation. 79% of cases were overseen by trauma and orthopaedic surgeons, 19% by plastic surgeons. Mean (±SD) inpatient hospital length of stay was 1.5 (±1.4) days in 2003-2004 and 1.0 (±1.3) days in 2007-2008. Total estimated costs for 1 year (2010-2011) were £41,576,141. Per-patient costs were £2,885 (day case) and £3,534 (inpatient). Costs ranged from £2,736 (day-case Fasciectomy) to £9,210 (day-case Revision Digital). CONCLUSIONS: Between 2003 and 2008, fasciectomy was the most common surgical procedure for DC in England. While procedure rates and physician specialties varied little, there was a reversal in surgical venue: inpatient operations decreased as day-case procedures increased. The change is likely due to economic trends and changes to the healthcare system. Estimated costs for 2010-2011 varied by procedure type and patient status. These findings can be used to understand clinical management of DC and guide healthcare policy. BioMed Central 2011-04-12 /pmc/articles/PMC3103491/ /pubmed/21486483 http://dx.doi.org/10.1186/1471-2474-12-73 Text en Copyright ©2011 Gerber et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Gerber, Robert A
Perry, Richard
Thompson, Robin
Bainbridge, Christopher
Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title_full Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title_fullStr Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title_full_unstemmed Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title_short Dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in England
title_sort dupuytren's contracture: a retrospective database analysis to assess clinical management and costs in england
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3103491/
https://www.ncbi.nlm.nih.gov/pubmed/21486483
http://dx.doi.org/10.1186/1471-2474-12-73
work_keys_str_mv AT gerberroberta dupuytrenscontracturearetrospectivedatabaseanalysistoassessclinicalmanagementandcostsinengland
AT perryrichard dupuytrenscontracturearetrospectivedatabaseanalysistoassessclinicalmanagementandcostsinengland
AT thompsonrobin dupuytrenscontracturearetrospectivedatabaseanalysistoassessclinicalmanagementandcostsinengland
AT bainbridgechristopher dupuytrenscontracturearetrospectivedatabaseanalysistoassessclinicalmanagementandcostsinengland